Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett King

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Journal of the American Academy of Dermatology|June 12, 2019
Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulareWilliam Damsky, Durga Thakral, Meaghan K McGeary, et al.
Dermatology Online Journal|November 25, 2014
Detailed protocol for administration of intralesional IL-2 for the treatment of Stage IIIc and IV M1a metastatic melanoma based on current NCCN guidelinesForum Patel, Reason Wilken, Barbara Burrall, et al.
ACR Open Rheumatology|January 10, 2020
Treatment of Multiorgan Sarcoidosis With TofacitinibWilliam Damsky, Bryan D Young, Brett Sloan, et al.
JAMA Dermatology|November 10, 2021
Treatment of Persistent Erythema Multiforme With Janus Kinase Inhibition and the Role of Interferon Gamma and Interleukin 15 in Its PathogenesisMichael J Murphy, Diana Gruenstein, Alice Wang, et al.
American Journal of Clinical Dermatology|October 23, 2024
Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical TrialRodney Sinclair, Natasha Mesinkovska, Debanjali Mitra, et al.
Archives of Dermatological Research|January 18, 2025
Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patientsRok Seon Choung, Jyoti Ramakrishna, Vivek Pradhan, et al.
Journal of the American Academy of Dermatology|September 17, 2013
Atypical hand-foot-and-mouth disease associated with coxsackievirus A6 infectionJason P Lott, Kristina Liu, Marie-Louise Landry, et al.
Dermatology and Therapy|September 26, 2021
Electrocardiogram Findings in Patients with Alopecia AreataDanielle Peterson, Carlos Wambier, Feng Dai, et al.
Dermatology (Basel, Switzerland)|June 27, 2024
Patient-Reported Satisfaction with Hair Regrowth in a Study of Ritlecitinib in Alopecia Areata: Results from ALLEGRO-2b/3Rodney Sinclair, Ernest H Law, Xingqi Zhang, et al.
Journal of Managed Care & Specialty Pharmacy|May 23, 2023
Overview of alopecia areata for managed care and payer stakeholders in the United StatesBrett King, Edmund Pezalla, Selwyn Fung, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Journal of the American Academy of Dermatology|June 12, 2019
Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulareWilliam Damsky, Durga Thakral, Meaghan K McGeary, et al.
Dermatology Online Journal|November 25, 2014
Detailed protocol for administration of intralesional IL-2 for the treatment of Stage IIIc and IV M1a metastatic melanoma based on current NCCN guidelinesForum Patel, Reason Wilken, Barbara Burrall, et al.
ACR Open Rheumatology|January 10, 2020
Treatment of Multiorgan Sarcoidosis With TofacitinibWilliam Damsky, Bryan D Young, Brett Sloan, et al.
JAMA Dermatology|November 10, 2021
Treatment of Persistent Erythema Multiforme With Janus Kinase Inhibition and the Role of Interferon Gamma and Interleukin 15 in Its PathogenesisMichael J Murphy, Diana Gruenstein, Alice Wang, et al.
American Journal of Clinical Dermatology|October 23, 2024
Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical TrialRodney Sinclair, Natasha Mesinkovska, Debanjali Mitra, et al.
Archives of Dermatological Research|January 18, 2025
Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patientsRok Seon Choung, Jyoti Ramakrishna, Vivek Pradhan, et al.
Journal of the American Academy of Dermatology|September 17, 2013
Atypical hand-foot-and-mouth disease associated with coxsackievirus A6 infectionJason P Lott, Kristina Liu, Marie-Louise Landry, et al.
Dermatology and Therapy|September 26, 2021
Electrocardiogram Findings in Patients with Alopecia AreataDanielle Peterson, Carlos Wambier, Feng Dai, et al.
Dermatology (Basel, Switzerland)|June 27, 2024
Patient-Reported Satisfaction with Hair Regrowth in a Study of Ritlecitinib in Alopecia Areata: Results from ALLEGRO-2b/3Rodney Sinclair, Ernest H Law, Xingqi Zhang, et al.
Journal of Managed Care & Specialty Pharmacy|May 23, 2023
Overview of alopecia areata for managed care and payer stakeholders in the United StatesBrett King, Edmund Pezalla, Selwyn Fung, et al.
Pageof 8